ARKG vs LQD
ARK Genomic Revolution ETF vs iShares iBoxx Investment Grade Corporate Bond ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
LQD—
iShares iBoxx Investment Grade Corporate Bond ETF
US investment-grade corporate bonds.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | LQD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
LQD top holdings
Holdings data unavailable for LQD.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About LQD
LQD (iShares iBoxx Investment Grade Corporate Bond ETF) is US investment-grade corporate bonds.